4-(2-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl)morpholine, 95%, 1g

5-iodo-1-methyl-1H-indazol-3-amine 95%, 1g

(R)-3-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-4-(4-cyanophenyl)butanoic acid, 97%, 1g

4-Chloro-5-iodo-2-(trifluoromethyl)pyridine, 95.0%, 1g

1-(3-BROMO-5-CHLOROPYRIDIN-2-YL)ETHANOL, 95.0%, 250mg

N-Phenyl-N-(phenylsulfonyl)glycine, 97%, 5g

Ethyl 2-(5-nitropyridin-2-yl)acetate, 95.0%, 1g

Ethyl 2-(2,4-Dimethyl-1,3-dioxolan-2-yl)acetate (mixture of diastereoisomers)>98.0%(GC)25g

8-Chloro-7-iodo-2-methylimidazo[1,2-a]pyridine, 97%, 100mg

1,3-Dimethyluracil-5-carboxaldehyde, 95.0%, 1g

1-Methylcyclopropane-1-carboxylic Acid>98.0%(GC)(T)25g

Solución estándar de holmio ICP, ROTI®Star, 10000 mg/l Ho, densidad (D) ~1 g/cm³

(S)-2-Amino-2-(3-bromo-4-chlorophenyl)ethanol, 95%, 100mg